The Influence of Cisplatin on Functionality and Surface Characteristics of Mesenchymal Stromal Cells In Vitro
Armin von Fournier, Totta Ehret Kasemo, Miguel Goncalves, Stephan Hackenberg, Marietta Herrmann, Marianne Schmidt, Manuel Stöth, Till Meyer, Thomas Gehrke, Agmal Scherzad · 2025
Read The Influence of Cisplatin on Functionality and Surface Characteristics of Mesenchymal Stromal Cells In Vitro by Armin von Fournier, Totta Ehret Kasemo, Miguel Goncalves, Stephan Hackenberg, Marietta Herrmann, Marianne Schmidt, Manuel Stöth, Till Meyer, Thomas Gehrke, Agmal Scherzad (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12786217.txt.
Description
Armin von Fournier and nine co-authors present a 2025 lab study on how the chemotherapy drug cisplatin affects mesenchymal stromal cells. These cells support wound healing and can mature into fat, cartilage, and bone cells. Patients with head and neck cancer often receive cisplatin, yet its effect on their healing cells was unclear. The team grew cells from four human donors and exposed them to doses like those used in care.
At doses below the toxic level, the cells kept their defining surface markers and could still move and mature normally under the microscope. Gene tests hinted at shifts, though: a fat-related gene fell, while a cartilage-related gene rose. Bone-related gene activity stayed flat. The authors suggest cisplatin may quietly steer these cells away from fat formation. That shift could matter for patients already at risk of poor nutrition during cancer care.
Catalog record
| CREATOR | Armin von Fournier, Totta Ehret Kasemo, Miguel Goncalves, Stephan Hackenberg, Marietta Herrmann, Marianne Schmidt, Manuel Stöth, Till Meyer, Thomas Gehrke, Agmal Scherzad |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |